Cerebrospinal fluid (CSF) core markers of AD include Aβ, and phospho-tau (pTau) protein levels: robust evidence indicates that Aβ42/40 ratio decrease, and pTau and total Tau (tTau) increase in the CSF, reliably marking Alzheimer's continuum. Here, MAPT is linked to Alzheimer disease.